thromboembolic


Also found in: Thesaurus, Medical, Encyclopedia.
Related to thromboembolic: thrombotic, Thromboembolic disease

throm·bo·em·bo·lism

 (thrŏm′bō-ĕm′bə-lĭz′əm)
n.
The blocking of a blood vessel by a blood clot dislodged from its site of origin.

throm′bo·em·bol′ic (-ĕm-bŏl′ĭk) adj.

thromboembolic

(ˌθrɒmbəʊɛmˈbɒlɪk)
adj
(Pathology) relating to or caused by a thromboembolism
References in periodicals archive ?
We remain committed to providing strong protection for the significant global patient population affected by venous thromboembolic disease," commented Lindsay L.
His meta-analysis demonstrated lower risks of thromboembolic and cerebrovascular events with anastrozole and letrozole, compared with tamoxifen, but higher rates of hypercholes-terolemia and coronary heart disease.
Patients taking Avastin (bevacizumab) may be at a higher risk for serious arterial thromboembolic events, according to the Food and Drug Administration.
Six of these patients had a symptomatic thromboembolic event confirmed within the next 3 months (2 had a nonfatal PE and 4 had DVT), yielding a symptomatic complication rate of 0.
In contrast, the venous thromboembolic rate in statin users randomized to receive placebo was 0.
Food and Drug Administration (FDA) granted marketing approval of ATryn, developed through recombinant technology, for the prevention of peri-operative and peri-partum thromboembolic events in patients with hereditary antithrombin deficiency (HD AT), a rare and potentially fatal blood clotting disorder.
A warfarin regimen that keeps a patient in the INR target range less than half the time "is no better than placebo," and may actually harm patients by causing an excess of thromboembolic events or intracranial hemorrhages, said Dr.
BACKGROUND In the middle of the last decade several studies suggested an increased risk of thromboembolic events in women using the newer generation of oral contraceptives (OCs).
The guideline was updated to include recommendations regarding the use of darbepoetin alfa, which came to market after epoetin alfa, and to address risks of thromboembolic events associated with the use of both agents.
The occurrence of an idiopathic thromboembolic event in an elderly patient is associated with an increased risk of being diagnosed with colon cancer within the next 2 years, Dr.
Other outcomes measured included bone density, nonvertebral fractures, breast and endometrial cancer, thromboembolic disease, and other adverse events.